Prior authorizations and price transparency will be a main focus of advocacy for 2023.
The report features data regarding COVID-19, the labor shortage, and access to care.
71% of long COVID claimants to workers' compensation insurer were unable to return to work for six months or more.
The CDC is now assessing whether nirsevimab would be eligible for the Vaccines for Children program.
The supermarket chain is the latest mega-retailer to enter the digital healthcare space.